Auto - Parts
Compare Stocks
5 / 10Stock Comparison
FOXF vs BCAL vs MFIN vs DORM vs LCII
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Financial - Credit Services
Auto - Parts
Auto - Recreational Vehicles
FOXF vs BCAL vs MFIN vs DORM vs LCII — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Auto - Parts | Banks - Regional | Financial - Credit Services | Auto - Parts | Auto - Recreational Vehicles |
| Market Cap | $779M | $613M | $225M | $3.72B | $2.83B |
| Revenue (TTM) | $1.48B | $233M | $353M | $2.15B | $4.17B |
| Net Income (TTM) | $-300M | $63M | $47M | $190M | $202M |
| Gross Margin | 29.7% | 79.4% | 96.7% | 40.7% | 24.1% |
| Operating Margin | -18.0% | 37.8% | 50.5% | 15.6% | 7.0% |
| Forward P/E | 18.4x | 11.4x | 8.0x | 15.0x | 13.4x |
| Total Debt | $780M | $72M | $316M | $633M | $1.24B |
| Cash & Equiv. | $58M | $52M | $202M | $49M | $223M |
FOXF vs BCAL vs MFIN vs DORM vs LCII — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Fox Factory Holding… (FOXF) | 100 | 25.8 | -74.2% |
| Southern California… (BCAL) | 100 | 217.9 | +117.9% |
| Medallion Financial… (MFIN) | 100 | 410.3 | +310.3% |
| Dorman Products, In… (DORM) | 100 | 178.1 | +78.1% |
| LCI Industries (LCII) | 100 | 117.7 | +17.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FOXF vs BCAL vs MFIN vs DORM vs LCII
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, FOXF doesn't own a clear edge in any measured category.
BCAL has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 26.2%, EPS growth 7.8%
- 133.6% 10Y total return vs DORM's 129.7%
- PEG 0.36 vs LCII's 3.48
- 26.2% NII/revenue growth vs FOXF's 5.3%
MFIN is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 4 yrs, beta 1.15, yield 4.7%
- Beta 1.15, yield 4.7%, current ratio 27.10x
- NIM 7.3% vs BCAL's 4.2%
- Lower P/E (8.0x vs 13.4x)
DORM ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.85, Low D/E 42.9%, current ratio 3.09x
- Beta 0.85 vs FOXF's 1.55, lower leverage
- 7.6% ROA vs FOXF's -16.5%, ROIC 13.9% vs -24.2%
LCII is the clearest fit if your priority is momentum.
- +45.6% vs FOXF's -8.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.2% NII/revenue growth vs FOXF's 5.3% | |
| Value | Lower P/E (8.0x vs 13.4x) | |
| Quality / Margins | 27.1% margin vs FOXF's -20.2% | |
| Stability / Safety | Beta 0.85 vs FOXF's 1.55, lower leverage | |
| Dividends | 4.7% yield, 4-year raise streak, vs LCII's 3.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +45.6% vs FOXF's -8.6% | |
| Efficiency (ROA) | 7.6% ROA vs FOXF's -16.5%, ROIC 13.9% vs -24.2% |
FOXF vs BCAL vs MFIN vs DORM vs LCII — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FOXF vs BCAL vs MFIN vs DORM vs LCII — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MFIN leads in 2 of 6 categories
FOXF leads 0 • BCAL leads 0 • DORM leads 0 • LCII leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MFIN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LCII is the larger business by revenue, generating $4.2B annually — 17.9x BCAL's $233M. BCAL is the more profitable business, keeping 27.1% of every revenue dollar as net income compared to FOXF's -20.2%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.5B | $233M | $353M | $2.2B | $4.2B |
| EBITDAEarnings before interest/tax | -$196M | $92M | $111M | $377M | $385M |
| Net IncomeAfter-tax profit | -$300M | $63M | $47M | $190M | $202M |
| Free Cash FlowCash after capex | $12M | $57M | $126M | $71M | $245M |
| Gross MarginGross profit ÷ Revenue | +29.7% | +79.4% | +96.7% | +40.7% | +24.1% |
| Operating MarginEBIT ÷ Revenue | -18.0% | +37.8% | +50.5% | +15.6% | +7.0% |
| Net MarginNet income ÷ Revenue | -20.2% | +27.1% | +12.2% | +8.8% | +4.8% |
| FCF MarginFCF ÷ Revenue | +0.8% | +24.4% | +35.7% | +3.3% | +5.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.8% | — | — | +4.2% | +4.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +94.2% | -2.0% | +16.3% | -23.5% | +30.4% |
Valuation Metrics
MFIN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 5.4x trailing earnings, MFIN trades at a 71% valuation discount to DORM's 18.8x P/E. Adjusting for growth (PEG ratio), BCAL offers better value at 0.31x vs LCII's 4.01x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $779M | $613M | $225M | $3.7B | $2.8B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $633M | $340M | $4.3B | $3.8B |
| Trailing P/EPrice ÷ TTM EPS | -1.42x | 9.88x | 5.37x | 18.75x | 15.38x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.42x | 11.42x | 7.97x | 15.05x | 13.38x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.31x | — | 1.25x | 4.01x |
| EV / EBITDAEnterprise value multiple | — | 7.19x | 1.90x | 10.41x | 9.57x |
| Price / SalesMarket cap ÷ Revenue | 0.53x | 2.63x | 0.64x | 1.75x | 0.69x |
| Price / BookPrice ÷ Book value/share | 1.16x | 1.08x | 0.46x | 2.59x | 2.13x |
| Price / FCFMarket cap ÷ FCF | 28.89x | 10.77x | 1.78x | 49.18x | 10.16x |
Profitability & Efficiency
Evenly matched — BCAL and DORM each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
LCII delivers a 14.7% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-37 for FOXF. BCAL carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to FOXF's 1.16x. On the Piotroski fundamental quality scale (0–9), LCII scores 8/9 vs FOXF's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -37.0% | +11.4% | +9.4% | +13.1% | +14.7% |
| ROA (TTM)Return on assets | -16.5% | +1.6% | +1.6% | +7.6% | +6.3% |
| ROICReturn on invested capital | -24.2% | +10.6% | +17.2% | +13.9% | +9.1% |
| ROCEReturn on capital employed | -30.9% | +5.0% | +10.0% | +18.5% | +10.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 7 | 7 | 8 |
| Debt / EquityFinancial leverage | 1.16x | 0.12x | 0.62x | 0.43x | 0.91x |
| Net DebtTotal debt minus cash | $722M | $20M | $115M | $584M | $1.0B |
| Cash & Equiv.Liquid assets | $58M | $52M | $202M | $49M | $223M |
| Total DebtShort + long-term debt | $780M | $72M | $316M | $633M | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | -5.17x | 1.55x | 1.07x | 8.24x | 5.49x |
Total Returns (Dividends Reinvested)
Evenly matched — BCAL and MFIN each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BCAL five years ago would be worth $14,274 today (with dividends reinvested), compared to $1,158 for FOXF. Over the past 12 months, LCII leads with a +45.6% total return vs FOXF's -8.6%. The 3-year compound annual growth rate (CAGR) favors MFIN at 16.7% vs FOXF's -42.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +6.6% | +3.3% | -4.9% | +0.3% | -5.4% |
| 1-Year ReturnPast 12 months | -8.6% | +32.9% | +8.2% | +0.5% | +45.6% |
| 3-Year ReturnCumulative with dividends | -80.6% | +47.7% | +58.9% | +41.6% | +11.2% |
| 5-Year ReturnCumulative with dividends | -88.4% | +42.7% | +23.2% | +19.2% | -6.1% |
| 10-Year ReturnCumulative with dividends | +7.0% | +133.6% | +60.3% | +129.7% | +111.5% |
| CAGR (3Y)Annualised 3-year return | -42.1% | +13.9% | +16.7% | +12.3% | +3.6% |
Risk & Volatility
Evenly matched — BCAL and DORM each lead in 1 of 2 comparable metrics.
Risk & Volatility
DORM is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than FOXF's 1.55 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BCAL currently trades 93.2% from its 52-week high vs FOXF's 59.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.55x | 0.90x | 1.15x | 0.85x | 0.99x |
| 52-Week HighHighest price in past year | $31.18 | $20.47 | $11.00 | $166.89 | $159.66 |
| 52-Week LowLowest price in past year | $13.08 | $14.07 | $7.88 | $98.44 | $82.29 |
| % of 52W HighCurrent price vs 52-week peak | +59.6% | +93.2% | +86.9% | +74.6% | +72.9% |
| RSI (14)Momentum oscillator 0–100 | 57.0 | 62.0 | 55.0 | 71.2 | 45.6 |
| Avg Volume (50D)Average daily shares traded | 658K | 189K | 59K | 273K | 352K |
Analyst Outlook
Evenly matched — MFIN and LCII each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FOXF as "Buy", BCAL as "Buy", MFIN as "Hold", DORM as "Buy", LCII as "Hold". Consensus price targets imply 29.3% upside for LCII (target: $151) vs 12.4% for DORM (target: $140). For income investors, MFIN offers the higher dividend yield at 4.73% vs BCAL's 0.52%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $21.50 | $22.00 | — | $140.00 | $150.60 |
| # AnalystsCovering analysts | 18 | 3 | 9 | 16 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | +0.5% | +4.7% | — | +3.9% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 4 | 2 | 9 |
| Dividend / ShareAnnual DPS | — | $0.10 | $0.45 | — | $4.59 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +1.0% | +0.4% | +1.1% | +4.5% |
MFIN leads in 2 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 4 categories are tied.
FOXF vs BCAL vs MFIN vs DORM vs LCII: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FOXF or BCAL or MFIN or DORM or LCII a better buy right now?
For growth investors, Southern California Bancorp (BCAL) is the stronger pick with 26.
2% revenue growth year-over-year, versus 5. 3% for Fox Factory Holding Corp. (FOXF). Medallion Financial Corp. (MFIN) offers the better valuation at 5. 4x trailing P/E (8. 0x forward), making it the more compelling value choice. Analysts rate Fox Factory Holding Corp. (FOXF) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FOXF or BCAL or MFIN or DORM or LCII?
On trailing P/E, Medallion Financial Corp.
(MFIN) is the cheapest at 5. 4x versus Dorman Products, Inc. at 18. 8x. On forward P/E, Medallion Financial Corp. is actually cheaper at 8. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Southern California Bancorp wins at 0. 36x versus LCI Industries's 3. 48x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FOXF or BCAL or MFIN or DORM or LCII?
Over the past 5 years, Southern California Bancorp (BCAL) delivered a total return of +42.
7%, compared to -88. 4% for Fox Factory Holding Corp. (FOXF). Over 10 years, the gap is even starker: BCAL returned +133. 6% versus FOXF's +7. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FOXF or BCAL or MFIN or DORM or LCII?
By beta (market sensitivity over 5 years), Dorman Products, Inc.
(DORM) is the lower-risk stock at 0. 85β versus Fox Factory Holding Corp. 's 1. 55β — meaning FOXF is approximately 82% more volatile than DORM relative to the S&P 500. On balance sheet safety, Southern California Bancorp (BCAL) carries a lower debt/equity ratio of 12% versus 116% for Fox Factory Holding Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — FOXF or BCAL or MFIN or DORM or LCII?
By revenue growth (latest reported year), Southern California Bancorp (BCAL) is pulling ahead at 26.
2% versus 5. 3% for Fox Factory Holding Corp. (FOXF). On earnings-per-share growth, the picture is similar: Southern California Bancorp grew EPS 777. 3% year-over-year, compared to -82. 5% for Fox Factory Holding Corp.. Over a 3-year CAGR, DORM leads at 7. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FOXF or BCAL or MFIN or DORM or LCII?
Southern California Bancorp (BCAL) is the more profitable company, earning 27.
1% net margin versus -37. 1% for Fox Factory Holding Corp. — meaning it keeps 27. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MFIN leads at 50. 5% versus -35. 6% for FOXF. At the gross margin level — before operating expenses — MFIN leads at 96. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FOXF or BCAL or MFIN or DORM or LCII more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Southern California Bancorp (BCAL) is the more undervalued stock at a PEG of 0. 36x versus LCI Industries's 3. 48x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Medallion Financial Corp. (MFIN) trades at 8. 0x forward P/E versus 18. 4x for Fox Factory Holding Corp. — 10. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LCII: 29. 3% to $150. 60.
08Which pays a better dividend — FOXF or BCAL or MFIN or DORM or LCII?
In this comparison, MFIN (4.
7% yield), LCII (3. 9% yield), BCAL (0. 5% yield) pay a dividend. FOXF, DORM do not pay a meaningful dividend and should not be held primarily for income.
09Is FOXF or BCAL or MFIN or DORM or LCII better for a retirement portfolio?
For long-horizon retirement investors, Southern California Bancorp (BCAL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
90), 0. 5% yield, +133. 6% 10Y return). Fox Factory Holding Corp. (FOXF) carries a higher beta of 1. 55 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BCAL: +133. 6%, FOXF: +7. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FOXF and BCAL and MFIN and DORM and LCII?
These companies operate in different sectors (FOXF (Consumer Cyclical) and BCAL (Financial Services) and MFIN (Financial Services) and DORM (Consumer Cyclical) and LCII (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FOXF is a small-cap quality compounder stock; BCAL is a small-cap high-growth stock; MFIN is a small-cap high-growth stock; DORM is a small-cap quality compounder stock; LCII is a small-cap deep-value stock. BCAL, MFIN, LCII pay a dividend while FOXF, DORM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.